225 related articles for article (PubMed ID: 9367544)
1. Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463.
Wagner TL; Horton VL; Carlson GL; Myhre PE; Gibson SJ; Imbertson LM; Tomai MA
Cytokine; 1997 Nov; 9(11):837-45. PubMed ID: 9367544
[TBL] [Abstract][Full Text] [Related]
2. Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609.
Gibson SJ; Imbertson LM; Wagner TL; Testerman TL; Reiter MJ; Miller RL; Tomai MA
J Interferon Cytokine Res; 1995 Jun; 15(6):537-45. PubMed ID: 7553223
[TBL] [Abstract][Full Text] [Related]
3. Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463.
Imbertson LM; Beaurline JM; Couture AM; Gibson SJ; Smith RM; Miller RL; Reiter MJ; Wagner TL; Tomai MA
J Invest Dermatol; 1998 May; 110(5):734-9. PubMed ID: 9579537
[TBL] [Abstract][Full Text] [Related]
4. Cytokine induction in mice by the immunomodulator imiquimod.
Reiter MJ; Testerman TL; Miller RL; Weeks CE; Tomai MA
J Leukoc Biol; 1994 Feb; 55(2):234-40. PubMed ID: 7507969
[TBL] [Abstract][Full Text] [Related]
5. Cytokine induction by the immunomodulators imiquimod and S-27609.
Testerman TL; Gerster JF; Imbertson LM; Reiter MJ; Miller RL; Gibson SJ; Wagner TL; Tomai MA
J Leukoc Biol; 1995 Sep; 58(3):365-72. PubMed ID: 7665993
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod.
Gibson SJ; Lindh JM; Riter TR; Gleason RM; Rogers LM; Fuller AE; Oesterich JL; Gorden KB; Qiu X; McKane SW; Noelle RJ; Miller RL; Kedl RM; Fitzgerald-Bocarsly P; Tomai MA; Vasilakos JP
Cell Immunol; 2002; 218(1-2):74-86. PubMed ID: 12470615
[TBL] [Abstract][Full Text] [Related]
7. Effect of a novel topical immunomodulator, S-28463, on keratinocyte cytokine gene expression and production.
Fujisawa H; Shivji GM; Kondo S; Wang B; Tomai MA; Miller RL; Sauder DN
J Interferon Cytokine Res; 1996 Jul; 16(7):555-9. PubMed ID: 8836922
[TBL] [Abstract][Full Text] [Related]
8. Potential efficacy of imiquimod on immunity-related cytokines in murine skin in vivo and in human Langerhans cells in vitro.
Miao X; Luo D; Min W; Lin X; Wang D; Xu Y; Wu D
Int J Dermatol; 2012 Sep; 51(9):1116-22. PubMed ID: 22348684
[TBL] [Abstract][Full Text] [Related]
9. Cytokine mRNA levels in unmanipulated (ex vivo) and in vitro stimulated monkey PBMCs using a semi-quantitative RT-PCR and high sensitivity fluorescence-based detection strategy.
Benveniste O; Vaslin B; Villinger F; Le Grand R; Ansari AA; Dormont D
Cytokine; 1996 Jan; 8(1):32-41. PubMed ID: 8742064
[TBL] [Abstract][Full Text] [Related]
10. Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro.
Weeks CE; Gibson SJ
J Interferon Res; 1994 Apr; 14(2):81-5. PubMed ID: 8077768
[TBL] [Abstract][Full Text] [Related]
11. Effect of imiquimod on cytokine induction in first trimester trophoblasts.
Manlove-Simmons JM; Zaher FM; Tomai M; Gonik B; Svinarich DM
Infect Dis Obstet Gynecol; 2000; 8(2):105-11. PubMed ID: 10805366
[TBL] [Abstract][Full Text] [Related]
12. Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod.
Wagner TL; Ahonen CL; Couture AM; Gibson SJ; Miller RL; Smith RM; Reiter MJ; Vasilakos JP; Tomai MA
Cell Immunol; 1999 Jan; 191(1):10-9. PubMed ID: 9918682
[TBL] [Abstract][Full Text] [Related]
13. Effects of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression.
Kono T; Kondo S; Pastore S; Shivji GM; Tomai MA; McKenzie RC; Sauder DN
Lymphokine Cytokine Res; 1994 Apr; 13(2):71-6. PubMed ID: 8061117
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulating and antiviral activities of the imidazoquinoline S-28463.
Tomai MA; Gibson SJ; Imbertson LM; Miller RL; Myhre PE; Reiter MJ; Wagner TL; Tamulinas CB; Beaurline JM; Gerster JF
Antiviral Res; 1995 Nov; 28(3):253-64. PubMed ID: 8629817
[TBL] [Abstract][Full Text] [Related]
15. The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans' cells.
Burns RP; Ferbel B; Tomai M; Miller R; Gaspari AA
Clin Immunol; 2000 Jan; 94(1):13-23. PubMed ID: 10607486
[TBL] [Abstract][Full Text] [Related]
16. Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells.
Kasid A; Director EP; Stovroff MC; Lotze MT; Rosenberg SA
Cancer Res; 1990 Aug; 50(16):5072-6. PubMed ID: 1696166
[TBL] [Abstract][Full Text] [Related]
17. The immune response modifier imiquimod requires STAT-1 for induction of interferon, interferon-stimulated genes, and interleukin-6.
Bottrel RL; Yang YL; Levy DE; Tomai M; Reis LF
Antimicrob Agents Chemother; 1999 Apr; 43(4):856-61. PubMed ID: 10103191
[TBL] [Abstract][Full Text] [Related]
18. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
19. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif.
Zhang Y; Shoda LK; Brayton KA; Estes DM; Palmer GH; Brown WC
J Interferon Cytokine Res; 2001 Oct; 21(10):871-81. PubMed ID: 11711000
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
